To find out if addition of lignocaine 1.5mg/kg IV improves intubating condition compared to rocuronium 0.6mg/kg IV at 60s after induction.
Phase 2/3
Not yet recruiting
- Conditions
- Other specified symptoms and signsinvolving the digestive system and abdomen,
- Registration Number
- CTRI/2020/02/023568
- Lead Sponsor
- Amrita hospital
- Brief Summary
Rocuronium is a non depolarizing muscle relaxant used for rapid sequence induction in conditions where succinylcholine is contraindicated. In this randomised control study we would be looking forward to find out if addition of 1.5mg/kg lignocaine provides smooth intubating conditions compared to 0.6mg/kg rocuronium. We would also be looking at the hemodynamic response between both the groups.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 68
Inclusion Criteria
Age 18-60years ASA I-II.
Exclusion Criteria
Difficult airway Patients considered full stomach Neurological disorders BMI >30 When intubation lasts for more than 15s.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate if addition of 1.5mg/kg lignocaine improves intubating conditions compared to 0.6mg/kg rocuronium in adults at 60s after induction. February 2020 to August 2020
- Secondary Outcome Measures
Name Time Method To compare the hemodynamic response mean arterial pressure and heart rate between the two groups. February 2020 to August 2020
Trial Locations
- Locations (1)
Department of anaesthesia
🇮🇳Ernakulam, KERALA, India
Department of anaesthesia🇮🇳Ernakulam, KERALA, IndiaSneha SPrincipal investigator9900331854sneha9793@gmail.com